Reshma Mahtani

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

Milan Radovich, Guanglong Jiang, Bradley A. Hancock et al. · JAMA Oncology · 2020 · 292 citations · Full text

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer

Erica L. Mayer, Yue Ren, Nikhil Wagle et al. · Journal of Clinical Oncology · 2024 · 95 citations

Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive, Locally Advanced, or Metastatic Breast Cancer

Kathy D. Miller, Véronique Dièras, Nadia Harbeck et al. · Journal of Clinical Oncology · 2014 · 84 citations · Full text

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

Shanu Modi, Cristina Saura, Charles Henderson et al. · Breast Cancer Research and Treatment · 2013 · 69 citations · Full text

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

Hatem Soliman, Varsha Shah, Gordan Srkalović et al. · BMC Cancer · 2020 · 62 citations · Full text